Earnings call transcript: CytoSorbents Q1 2026 misses forecasts, stock falls

CytoSorbents, a medical device company, reported disappointing Q1 2026 earnings, falling short of investor expectations. The company's stock price declined following the release of the earnings call transcript. Revenue and profit margins failed to meet projected levels, contributing to the stock's decline.